Skip to content

Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort

Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01314547
Acronym
CoEnv
Enrollment
300
Registered
2011-03-14
Start date
2005-03-31
Completion date
2011-12-31
Last updated
2012-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Systemic Vasculitis, Spondylarthritis

Keywords

Environment, spondylarthritis, vasculitis, stress, life event, vaccine

Brief summary

Susceptibility to SPA has been shown to be largely genetically determined. The objective of this study was to prospectively investigate the impact of several environmental factors on disease activity.

Detailed description

Susceptibility to SPA has been shown to be largely genetically determined but the contribution of environmental factors to disease evolution has not yet been elucidated. The objective of this study was to prospectively investigate the impact of several environmental factors on disease activity.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years SPONDILARTHRITIS: modified New York criteria Systemic vasculitis: ACR criteria

Exclusion criteria

no internet access

Design outcomes

Primary

MeasureTime frameDescription
Score on a disease activity rating scaleSix yearsScore on a disease activity rating scale (quaterly,than monthly basis)

Secondary

MeasureTime frameDescription
Ancillary studies will be possible with the available databasesix yearsAncillary studies will be possible with the available database

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026